From April 15 to April 22, the 28th National Cancer Prevention and Control Publicity Week was held with the theme of “Early Cancer Prevention and Treatment”. He Jie, president of the Cancer Hospital of the Chinese Academy of Medical Sciences and director of the National Cancer Center, pointed out at the launch ceremony of this publicity week that early intervention is an important means to effectively reduce the incidence rate and mortality caused by cancer. 

Early diagnosis and treatment can significantly improve the 5-year survival rate of patients since no obvious symptoms would generate due to cancer at the early stage. Therefore, early screening, detection and treatment are important strategies to reduce cancer mortality, improve cure rate and quality of life. Eliminating cancer in its primary stage will be the focus of cancer prevention and control in the future.

The accordance of tumor markers detection is that some indicators in the human body would be abnormal during the occurrence and proliferation of tumor cells (such as substances produced abnormally by malignant tumor cells, or by the host in response to tumor stimulation). Monitoring these abnormalities in the tissues, body fluids and excreta of tumor patients can reflect the occurrence and development of tumors and monitor tumor response to treatment. Tumor markers serve as “signalman” for the existence and growth of tumors. 

Henderson raw materials for tumor markers have wide linear range, high sensitivity and strong specificity, which can provide strong support for early cancer diagnosis.

Whole Series of Henderson Raw Materials for Tumor Markers Detection

⬇⬇⬇

Performance of Some Tumor Markers Raw Materials

⬇⬇⬇

◆ CA 153 Antibody

The linear correlation was R2=0.9803 within the concentration range of 1U/mL-300U/mL verified on the chemiluminescence platform.

On the chemiluminescence platform, CA153 paired monoclonal antibody was used to detect the clinical serum assigned by the well-known R Company. The sample agreement rate was R2>97.5%.

◆ CA 125 Antibody

The linear correlation was R2=0.9742 within the concentration range of 0.6U/mL-5000U/mL verified on the chemiluminescence platform.

On the chemiluminescence platform, CA125 paired monoclonal antibody was used to detect the clinical serum assigned by the well-known R Company. The sample agreement rate was R2>0.979.

◆ CA 199 Antibody

The linear correlation was R2=0.9857 within the concentration range of 2U/mL-1000U/mL verified on the chemiluminescence platform.

On the chemiluminescence platform, CA199 paired monoclonal antibody was used to detect the clinical serum assigned by the well-known R Company. The sample agreement rate was R2>98.1%.

◆ Pro-GRP Antibody

The linear correlation was R2=0.9954 within the concentration range of 0pg/mL-5000pg/mL verified on the chemiluminescence platform.

On the chemiluminescence platform, Pro-GRP paired monoclonal antibody was used to detect the clinical serum assigned by the well-known R Company. The sample agreement rate was R2>98.5%.

——Limited space only allows the introduction of major products.——

⬇⬇⬇

You are welcomed to contact Qingdao Henderson Biotechnology Co., Ltd and acquire trial samples if you need more information!

Tel: 0532-84670782、15216817274

Email: info@qdhenderson.com

Qingdao Henderson Biotechnology Co., Ltd, established in 2016, serves as a professional supplier of core raw materials for in vitro diagnostic reagents and is committed to providing high-quality raw materials for global in vitro diagnostic reagent production enterprises, scientific research institutions and other fields.

The company provides the following staple products: antigens, antibodies, enzymes, etc., widely used in the detection of drug, respiratory infectious diseases (A, B, COVID-19 antigen, COVID-19 antibody, COVID-19 neutralizing antibody, syncytial virus, etc.), other infectious diseases (hepatitis, AIDS, tuberculosis, etc.), markers for tumor, inflammation, myocardial markers, animal diseases detection (dog, cat diseases) and other fields. 

The company, after years of development, has established several specialized laboratories and SPF experimental animal bases, a comprehensive and systematic R&D verification platform and formed a professional technical service team to provide personalized customized services and one-stop solutions.

Qingdao Henderson Biotechnology Co., Ltd is willing to build a renowned product brand for all customers with high-quality products and professional services to keep a foothold in the market with its sound competitiveness.

Official Website: /

Tel: 0532-84670782

E-mail: info@qdhenderson.com